PROVENGE (sipuleucel-T)
STN: BL 125197
Proper Name: sipuleucel-T
Tradename: PROVENGE
Manufacturer: Dendreon Corporation
Indication:
- For the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.
Product Information
Supporting Documents
- Supporting Documents older than three years - PROVENGE
- Approval History, Letters, Reviews, and Related Documents - Provenge